Case report of the dupilumab applying in atopic dermatitis child

0Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In recent years, there has been a clear trend towards an increase in the number of patients with severe atopic dermatitis. In most cases, patients are dissatisfied with the previous therapy, which requires hospital treatment to relieve acute manifes-tations of atopic dermatitis and the selection of pharmacological agents aimed at achieving long-term control under the of the disease symptoms The article presents the features of the atopic dermatitis therapy of at the present stage, the experience of using the new biological drug dupilumab in a 7-year-old child.

Cite

CITATION STYLE

APA

Revyakina, V. A., Larkova, I. A., Kuvshinova, E. D., Mukhortykh, V. A., & Melnikova, K. S. (2021). Case report of the dupilumab applying in atopic dermatitis child. Russian Journal of Allergy, 18(2), 115–122. https://doi.org/10.36691/RJA1424

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free